(Q33879368)

29 July 2017

title

Poxviral-based vaccine elicits immunologic responses in prostate cancer patients (English)

1 reference

29 July 2017

1 reference

3

James L Gulley

1 reference

29 July 2017

Ravi A Madan

1

1 reference

29 July 2017

Christopher R Heery

series ordinal

2

1 reference

29 July 2017

publication date

29 April 2014

1 reference

29 July 2017

1 reference

29 July 2017

volume

3

1 reference

29 July 2017

page(s)

e28611

1 reference

Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091323

Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091323

Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091323

Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091323

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091323

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091323

Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091323

Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091323

High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FONCI.28611

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FONCI.28611

21 January 2018

Identifiers

DOI

10.4161/ONCI.28611

1 reference

29 July 2017

1 reference

29 July 2017

1 reference